• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用 PEI-PEG-APRPG 聚合物的小干扰 RNA 递药系统用于抗血管生成血管内皮生长因子肿瘤靶向治疗。

Development of small interfering RNA delivery system using PEI-PEG-APRPG polymer for antiangiogenic vascular endothelial growth factor tumor-targeted therapy.

机构信息

Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, People's Republic of China.

出版信息

Int J Nanomedicine. 2011;6:1661-73. doi: 10.2147/IJN.S22293. Epub 2011 Aug 11.

DOI:10.2147/IJN.S22293
PMID:21904456
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3160952/
Abstract

BACKGROUND

Small interfering RNA (siRNA) can silence target genes in the cytoplasm and be a major tool in gene therapy. Vascular endothelial growth factor (VEGF), a potent regulator of angiogenesis, is overexpressed in most tumors and is closely associated with tumor growth and metastasis. It has been shown that inhibition of VEGF expression by siRNA is an effective and useful method for antiangiogenic tumor therapy.

METHODS

In the present study, we synthesized a targeted delivery system of PEI-PEG-APRPG incorporating angiogenic vessel-homing Ala-Pro-Arg-Pro-Gly (APRPG) peptide into cationic polyethylenimine (PEI) via a hydrophilic poly(ethylene glycol) (PEG) spacer.

RESULTS

PEI-PEG-APRPG effectively condensed siRNA into 20-50 nm nanoparticles with a positive surface charge using a suitable N/P ratio. The siRNA/PEI-PEG-APRPG complex effectively enhanced the stability of siRNA in RNase A, and improved the proliferation-inhibiting ability and transfection efficiency of siRNA in vitro and tumor accumulation in vivo. In addition, the siRNA/PEI-PEG-APRPG complex exhibited high efficiency as antitumor therapy with regard to tumor growth, microvessel density, and VEGF protein and mRNA levels.

CONCLUSION

These findings suggest that PEI-PEG-APRPG effectively delivers siRNA to tumors overexpressing VEGF and thereby inhibits tumor growth.

摘要

背景

小干扰 RNA(siRNA)可在细胞质中沉默靶基因,是基因治疗的主要工具。血管内皮生长因子(VEGF)是血管生成的有力调节剂,在大多数肿瘤中过度表达,与肿瘤生长和转移密切相关。研究表明,通过 siRNA 抑制 VEGF 表达是一种有效的抗血管生成肿瘤治疗方法。

方法

在本研究中,我们合成了一种靶向递送系统,将含有血管生成血管靶向 Ala-Pro-Arg-Pro-Gly(APRPG)肽的聚乙二醇(PEG)接枝到阳离子聚乙烯亚胺(PEI)上。

结果

PEI-PEG-APRPG 在合适的 N/P 比下,能有效地将 siRNA 凝聚成 20-50nm 的带有正表面电荷的纳米颗粒。siRNA/PEI-PEG-APRPG 复合物能有效提高 siRNA 在 RNase A 中的稳定性,并提高 siRNA 在体外的增殖抑制能力和转染效率以及体内肿瘤积累。此外,siRNA/PEI-PEG-APRPG 复合物在肿瘤生长、微血管密度以及 VEGF 蛋白和 mRNA 水平方面具有高效的抗肿瘤治疗作用。

结论

这些发现表明,PEI-PEG-APRPG 能有效地将 siRNA 递送到过度表达 VEGF 的肿瘤中,从而抑制肿瘤生长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db45/3160952/f53b3f35f77e/ijn-6-1661f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db45/3160952/16eb7246b4c6/ijn-6-1661f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db45/3160952/66ee668d3a07/ijn-6-1661f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db45/3160952/90e589ea95fb/ijn-6-1661f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db45/3160952/9efe0841c708/ijn-6-1661f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db45/3160952/a2df4dea33a2/ijn-6-1661f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db45/3160952/ba9f1888b221/ijn-6-1661f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db45/3160952/23d3d222e6a6/ijn-6-1661f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db45/3160952/8777ea289673/ijn-6-1661f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db45/3160952/f53b3f35f77e/ijn-6-1661f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db45/3160952/16eb7246b4c6/ijn-6-1661f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db45/3160952/66ee668d3a07/ijn-6-1661f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db45/3160952/90e589ea95fb/ijn-6-1661f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db45/3160952/9efe0841c708/ijn-6-1661f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db45/3160952/a2df4dea33a2/ijn-6-1661f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db45/3160952/ba9f1888b221/ijn-6-1661f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db45/3160952/23d3d222e6a6/ijn-6-1661f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db45/3160952/8777ea289673/ijn-6-1661f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db45/3160952/f53b3f35f77e/ijn-6-1661f9.jpg

相似文献

1
Development of small interfering RNA delivery system using PEI-PEG-APRPG polymer for antiangiogenic vascular endothelial growth factor tumor-targeted therapy.采用 PEI-PEG-APRPG 聚合物的小干扰 RNA 递药系统用于抗血管生成血管内皮生长因子肿瘤靶向治疗。
Int J Nanomedicine. 2011;6:1661-73. doi: 10.2147/IJN.S22293. Epub 2011 Aug 11.
2
Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.体内的聚乙烯亚胺/小干扰 RNA 介导的血管内皮生长因子敲低与贝伐单抗联合使用具有协同的抗肿瘤作用。
J Gene Med. 2010 Mar;12(3):287-300. doi: 10.1002/jgm.1431.
3
Advanced cancer therapy by integrative antitumor actions via systemic administration of miR-499.通过全身给予 miR-499 进行整合抗肿瘤作用的癌症先进疗法。
J Control Release. 2014 May 10;181:32-9. doi: 10.1016/j.jconrel.2014.02.019. Epub 2014 Mar 2.
4
Soluble Flt-1 gene delivery using PEI-g-PEG-RGD conjugate for anti-angiogenesis.使用聚乙二醇化聚乙烯亚胺-聚乙二醇-精氨酸-甘氨酸-天冬氨酸共轭物递送可溶性Flt-1基因用于抗血管生成
J Control Release. 2005 Aug 18;106(1-2):224-34. doi: 10.1016/j.jconrel.2005.04.016.
5
Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.低分子量聚亚乙基亚胺交联 2-羟丙基-β-环糊精和叶酸作为高效无毒的 siRNA 载体,通过 VEGF siRNA 抑制基因表达和肿瘤生长。
Int J Nanomedicine. 2013;8:2101-17. doi: 10.2147/IJN.S42440. Epub 2013 Jun 5.
6
Efficient and Tumor Targeted siRNA Delivery by Polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol).聚乙烯亚胺接枝聚己内酯-嵌段-聚(乙二醇)-叶酸(PEI-PCL-PEG-Fol)介导的高效肿瘤靶向性小干扰RNA递送
Mol Pharm. 2016 Jan 4;13(1):134-43. doi: 10.1021/acs.molpharmaceut.5b00575. Epub 2015 Dec 16.
7
Prostate cancer cell-specific VEGF siRNA delivery system using cell targeting peptide conjugated polyplexes.使用靶向细胞肽偶联的多聚物的前列腺癌细胞特异性 VEGF siRNA 递释系统。
J Drug Target. 2009 May;17(4):311-7. doi: 10.1080/10611860902767232.
8
Specific cell targeting with APRPG conjugated PEG-PLGA nanoparticles for treating ovarian cancer.APRPG 缀合的 PEG-PLGA 纳米粒对卵巢癌细胞的靶向治疗。
Biomaterials. 2014 Jan;35(3):983-92. doi: 10.1016/j.biomaterials.2013.09.062. Epub 2013 Oct 28.
9
Effective delivery of an angiogenesis inhibitor by neovessel-targeted liposomes.通过新血管靶向脂质体有效递送血管生成抑制剂。
Int J Pharm. 2008 Aug 6;360(1-2):219-24. doi: 10.1016/j.ijpharm.2008.04.046. Epub 2008 May 13.
10
PEI-g-PEG-RGD/small interference RNA polyplex-mediated silencing of vascular endothelial growth factor receptor and its potential as an anti-angiogenic tumor therapeutic strategy.聚乙烯亚胺接枝聚乙二醇-精氨酸-甘氨酸-天冬氨酸/小干扰RNA多聚体介导的血管内皮生长因子受体沉默及其作为抗血管生成肿瘤治疗策略的潜力
Oligonucleotides. 2011 Mar-Apr;21(2):101-7. doi: 10.1089/oli.2011.0278. Epub 2011 Mar 4.

引用本文的文献

1
Tumor-Homing Peptides as Crucial Component of Magnetic-Based Delivery Systems: Recent Developments and Pharmacoeconomical Perspective.肿瘤归巢肽作为基于磁性的递药系统的关键组成部分:最新进展和药物经济学视角。
Int J Mol Sci. 2024 Jun 5;25(11):6219. doi: 10.3390/ijms25116219.
2
Biodistribution of degradable polyanhydride particles in Aedes aegypti tissues.可降解聚酸酐颗粒在埃及伊蚊组织中的分布。
PLoS Negl Trop Dis. 2020 Sep 8;14(9):e0008365. doi: 10.1371/journal.pntd.0008365. eCollection 2020 Sep.
3
Lipid and Polymer-Based Nanoparticle siRNA Delivery Systems for Cancer Therapy.

本文引用的文献

1
Polyethylenimine-PEG coated albumin nanoparticles for BMP-2 delivery.聚乙烯亚胺-聚乙二醇包裹的白蛋白纳米颗粒用于骨形态发生蛋白-2 的递送。
Biomaterials. 2010 Feb;31(5):952-63. doi: 10.1016/j.biomaterials.2009.10.011. Epub 2009 Oct 29.
2
A novel DDS strategy, "dual-targeting", and its application for antineovascular therapy.一种新的 DDS 策略,“双重靶向”及其在抗血管生成治疗中的应用。
Cancer Lett. 2010 Jan 28;287(2):165-71. doi: 10.1016/j.canlet.2009.06.008. Epub 2009 Jul 17.
3
siRNA delivery systems for cancer treatment.用于癌症治疗的小干扰RNA递送系统。
基于脂质和聚合物的纳米颗粒 siRNA 递药系统用于癌症治疗。
Molecules. 2020 Jun 10;25(11):2692. doi: 10.3390/molecules25112692.
4
Targeted Delivery of siRNA Therapeutics to Malignant Tumors.将小干扰RNA治疗药物靶向递送至恶性肿瘤
J Drug Deliv. 2017;2017:6971297. doi: 10.1155/2017/6971297. Epub 2017 Nov 9.
5
Nanoparticles for siRNA-Based Gene Silencing in Tumor Therapy.用于肿瘤治疗中基于siRNA的基因沉默的纳米颗粒。
IEEE Trans Nanobioscience. 2016 Dec;15(8):849-863. doi: 10.1109/TNB.2016.2621730.
6
Nanoparticles for imaging and treatment of metastatic breast cancer.用于转移性乳腺癌成像和治疗的纳米颗粒。
Expert Opin Drug Deliv. 2017 Jan;14(1):123-136. doi: 10.1080/17425247.2016.1208650. Epub 2016 Jul 19.
7
Enhanced EJ Cell Killing of (125)I Radiation by Combining with Cytosine Deaminase Gene Therapy Regulated by Synthetic Radio-Responsive Promoter.通过与受合成辐射响应启动子调控的胞嘧啶脱氨酶基因治疗联合增强(125)I 辐射对 EJ 细胞的杀伤作用。
Cancer Biother Radiopharm. 2015 Oct;30(8):342-8. doi: 10.1089/cbr.2015.1862. Epub 2015 Sep 18.
8
Polymer nanoparticles for drug and small silencing RNA delivery to treat cancers of different phenotypes.聚合物纳米粒用于药物和小干扰 RNA 的递送来治疗不同表型的癌症。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014 Jan-Feb;6(1):40-60. doi: 10.1002/wnan.1242. Epub 2013 Aug 31.
9
Subtle changes to polymer structure and degradation mechanism enable highly effective nanoparticles for siRNA and DNA delivery to human brain cancer.聚合物结构和降解机制的细微变化使高效的纳米颗粒能够将 siRNA 和 DNA 递送到人脑癌细胞。
Adv Healthc Mater. 2013 Mar;2(3):468-80. doi: 10.1002/adhm.201200257. Epub 2012 Sep 26.
Adv Drug Deliv Rev. 2009 Aug 10;61(10):850-62. doi: 10.1016/j.addr.2009.04.018. Epub 2009 May 5.
4
Effects of nanomaterial physicochemical properties on in vivo toxicity.纳米材料物理化学性质对体内毒性的影响。
Adv Drug Deliv Rev. 2009 Jun 21;61(6):457-66. doi: 10.1016/j.addr.2009.03.010. Epub 2009 Apr 20.
5
Effective delivery of an angiogenesis inhibitor by neovessel-targeted liposomes.通过新血管靶向脂质体有效递送血管生成抑制剂。
Int J Pharm. 2008 Aug 6;360(1-2):219-24. doi: 10.1016/j.ijpharm.2008.04.046. Epub 2008 May 13.
6
Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer.使用聚电解质复合胶束进行VEGF小干扰RNA的局部和全身递送以有效治疗癌症。
J Control Release. 2008 Jul 14;129(2):107-16. doi: 10.1016/j.jconrel.2008.03.008. Epub 2008 Mar 14.
7
Synthesis and characterization of folate-PEG-grafted-hyperbranched-PEI for tumor-targeted gene delivery.用于肿瘤靶向基因递送的叶酸-聚乙二醇接枝超支化聚乙烯亚胺的合成与表征
Biochem Biophys Res Commun. 2008 Mar 21;367(4):874-80. doi: 10.1016/j.bbrc.2008.01.024. Epub 2008 Jan 15.
8
Synthesis of 2'-O-modified adenosine building blocks and application for RNA interference.2'-O-修饰的腺苷构建模块的合成及其在RNA干扰中的应用。
Bioorg Med Chem. 2008 Jan 1;16(1):518-29. doi: 10.1016/j.bmc.2007.09.019. Epub 2007 Sep 15.
9
Suppression of immunostimulatory siRNA-driven innate immune activation by 2'-modified RNAs.2'-修饰的RNA对免疫刺激siRNA驱动的先天性免疫激活的抑制作用。
Biochem Biophys Res Commun. 2007 Sep 14;361(1):122-6. doi: 10.1016/j.bbrc.2007.06.177. Epub 2007 Jul 16.
10
Strategies for silencing human disease using RNA interference.利用RNA干扰沉默人类疾病的策略。
Nat Rev Genet. 2007 Mar;8(3):173-84. doi: 10.1038/nrg2006.